GTP Bioways is attending NLSDays 2024
GTP Bioways is attending NLSDays 2024, taking place on September 18th–19th, 2024, in Malmö, Sweden.
NLSDays stands as the premier Nordic partnering conference in the life science sector, offering a platform to connect with leading figures across biotech, pharma, finance, research, policy, and regulatory arenas. This event presents a golden opportunity to forge valuable connections and explore exciting collaborative prospects.
NLSDays is a must attend event to discover the latest topics in the industry and with amazing opportunities to connect. In In 2023, over 1,640 delegates from more than 900 companies and organisations across 30 countries participated.
Mélusine Larivière, Business Development Manager at GTP Bioways will be representing us at the event. Cease the opportunity to connect with her by emailing her directly or through EBD Group’s PartneringONE™ platform.
Explore Our Tailored Solutions for Your Drug Development Needs
If you’re a biotech company seeking a CDMO to elevate your drug development project, you’ve come to the right place. We’re excited to connect with you and showcase how our comprehensive CDMO services can support your journey from early development through to commercialisation.
At the heart of our approach is flexibility combined with deep expertise. We offer a wide range of services designed to adapt to the unique requirements of your project, whether you’re working with microbial or mammalian expression systems. This versatility ensures that we can handle the diverse needs of biotech innovations. We specialise in process development, preclinical/ clinical manufacturing, and analytical development services. With a strong commitment to quality, we guarantee that your biologic therapies will meet the highest standards and comply with all regulatory requirements.
We look forward to discussing how our tailored solutions can advance your drug development project and help you achieve your goals.
